Robert L. Jones

Robert L. Jones has a broad corporate law practice devoted to the representation of technology companies, and particularly companies in the life sciences industries. His practice includes the full range of corporate and securities law matters, including public and private financings, advice regarding disclosure issues and securities law compliance and fiduciary issues. Previously, he served as the firm's business department chair and chair of the firm's life sciences practice.

Robert is one of the country's leading practitioners for the representation of biotechnology companies. He is particularly well known for his work in the field of licensing and corporate partnering transactions. His biotechnology clients include, by way of example, Otsuka Pharmaceuticals, Portola Pharmaceuticals, Rigel Pharmaceuticals, Cytokinetics, Five Prime Therapeutics, Exelixis, Gilead Sciences and Onyx Pharmaceuticals.

Robert is consistently recognized as a leading attorney. He has been recognized by Chambers USA: America's Leading Lawyers for Business both nationally and in California from 2007–2016 and 2018 – 2021, and is consistently listed in The Best Lawyers in America. He is also listed as leading lawyer in the Healthcare & Life Sciences category in the 2011–2016 editions of the Legal 500: United States Client Guide and has been recognized as a Northern California Super Lawyer since 2004.

In 1979, Robert received a JD degree from Stanford Law School, where he was elected to Order of the Coif, and an MBA degree from Stanford Graduate School of Business, where he received the Henry Ford II Scholar award for highest academic achievement. He also served as managing editor of the Stanford Journal of International Studies. Robert received a BA degree in 1975 from Swarthmore College, with a major in Economics.

Robert previously served as an instructor of Management at the Stanford Graduate School of Business, where he taught the course in Social and Ethical Issues in the Pharmaceutical and Biotechnology Industries.